Morepen Laboratories has informed that the Board of Directors of the Company, in its meeting held on Tuesday, 04th May, 2021 (commenced at 09:50 am and concluded at 10:22 am) have considered and approved the audited standalone and consolidated financial results of the Company for the quarter and financial year ended 31st March, 2021, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. A copy of the 'Results' along with the Report of the Auditors of the Company, with unmodified opinion, thereon and a declaration to that effect is enclosed.
The above information is a part of company’s filings submitted to BSE.
